Perfecting The European Medtech Accelerator And Funding Vehicle
Executive Summary
Sofinnova Partners’ early-stage, "stay lean" approach to funding and incubating innovative medtech is unique in Europe, believes partner Anne Osdoit. She is seeking more investments for the company’s major MD Start III fund, while trying not to focus too much on thoughts of the next iteration.
You may also be interested in...
On-Demand Robotics The Way Forward In Minimally Invasive Surgery
Focus On Switzerland – Part 3: Robotics means different things to different surgeons, according to Swiss innovator Distalmotion, whose surgical robot combines with laparoscopy to leave the surgeon fully in control in the OR.
NICE: Real-World Evidence Revolution Will Drive UK’s Health Care Innovation
In its just-released real-world evidence framework, NICE assesses the role and value of data collected outside highly-controlled clinical studies in driving more innovation towards health care professionals.
EU Medtech Industry Keeps Watchful Eye On Changing Needs In Ukraine
Ukraine’s medical supply needs have evolved since Russia launched its military invasion of the country on 24 February. EU healthcare decision makers and the medical technology industry have since stood firm in their support of the besieged country, said MedTech Europe’s Jesús Rueda.